Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.98, read 2026-11-03
Ethical does not pass the values gate
Price270.16 USD
Fair value320.00
Ethical score70.0/100
Value readUndervaluedas of 5 Nov 2026
Our investment reviews on this name
2026-10-29Read Markup270.90-0.3% to today Accumulation gives way to Markup after a 15% rise in 9 days
2026-10-20Read Accumulation236.04+14.5% to today ✓Markdown gives way to Accumulation with results news in the headlines
2026-09-10Read Markdown246.18+9.7% to today Markup gives way to Markdown after a 12% slide in 10 weeks
2026-07-02Read Markup280.33-3.6% to today First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Ryder System, Inc. holds its Markup at $270.16. Consolidating, no directional conviction, held for 15 days.
As held on the ledger · 2026-11-05
Phase
Markup
Quantitative state
Consolidating, no directional conviction, held for 15 days
Price at the screen
$270.16
Valuation
21.46 trailing · 15.54 forward price to earnings
Values screen
FAIL· score 70.0
Beta
1.03
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
52.97%
Below 33%
Interest-bearing debt is 53.0% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
11.38%
Below 49%
Money owed to the company is 11.4% of assets, under the 49% limit.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Ryder System,'s business is in a permissible area, but its interest-bearing debt is about 53% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when R's ethical verdict changes
Today R does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 5 Nov 2026: it trades at roughly a 12% discount to our $320.00 fair value, 8.30% revenue growth.
Fair value range in USD, drawn from the 2026-11-05 screen. The gold marker is the market price at the same screen. A 15.6% discount to the base estimate.
Where our models see it going: fair-value estimate $320.00, with a range of $272.02 to $453.36, dated to the 2026-11-05 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Trucks idling while the cycle turns
Picture a logistics yard where the lorries sit ready but bookings stay flat. Ryder runs fleet leasing, dedicated haulage and supply-chain work across three segments, yet revenue shows zero growth and margins sit at just 4 percent. The shares trade at 15.4 times forward earnings with a modest 14 percent gap to our fair value, and the consensus target sits below the current price.
We pass because the business offers no clear edge. Return on equity reaches 17 percent, yet that figure comes against a backdrop of no revenue expansion and an unknown competitive moat. A low multiple on flat earnings often signals peak-cycle profits rather than a bargain, and the ethical screen raises no red flags.
Transportation demand moves with the economy, so any slowdown hits utilisation and pricing fast. Currency and fuel swings add further pressure on an already thin margin base. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
R trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-05Markup$283.12+4.5%Entry 16
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 4.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 22% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 79%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (8 analysts) rates it buy, with a mean price target of $261. Insiders have been net sellers over the past quarter.
2026-10-29Markup · changed$270.90+14.8%Entry 15
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 14.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 22% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 79%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (8 analysts) rates it buy, with a mean price target of $261.
2026-10-22Accumulation$236.04+0.0%Entry 14
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 79%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (8 analysts) rates it buy, with a mean price target of $261. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-21Accumulation$236.04+0.0%Entry 13
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 79%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (8 analysts) rates it buy, with a mean price target of $261. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 79%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (8 analysts) rates it buy, with a mean price target of $261. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-19Markdown$237.82+0.0%Entry 11
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 79%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (8 analysts) rates it buy, with a mean price target of $261. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-18Markdown$237.82+0.0%Entry 10
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 27% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 79%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (8 analysts) rates it buy, with a mean price target of $261. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-17Markdown$237.82+0.0%Entry 9
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 27% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 79%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (8 analysts) rates it buy, with a mean price target of $261. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-16Markdown$237.82-0.3%Entry 8
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 27% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 79%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (8 analysts) rates it buy, with a mean price target of $261. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-15Markdown$238.55+3.3%Entry 7
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 3.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 27% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 79%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (8 analysts) rates it buy, with a mean price target of $261. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.